Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice

被引:2
|
作者
Huang, Yuzhe [1 ,2 ,3 ,4 ]
Chen, Hao [1 ,4 ]
Chen, Jielin [1 ,4 ]
Wu, Qingxi [1 ,4 ]
Zhang, Wenna [1 ,4 ]
Li, Daxiang [5 ]
Lu, Yongming [1 ,4 ]
Chen, Yan [1 ,4 ]
机构
[1] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China
[2] Anhui Univ Chinese Med, Dept Pharm, Hefei 230012, Anhui, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei 230012, Anhui, Peoples R China
[4] Key Lab Ecol Engn & Biotechnol Anhui Prov, Hefei 230601, Peoples R China
[5] Anhui Agr Univ, Sch Tea & Food Sci, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China
关键词
Yellow tea; Polysaccharies; NAFLD; Targeted metabolomics; Gut microbiota; RECEPTOR;
D O I
10.1016/j.phymed.2024.155919
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear. Purpose: This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice. Methods: The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism. Results: Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers. Conclusions: YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential pro- biotic formulation, offering a feasible dietary intervention for NAFLD.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
    Zhang, Xiao-Lei
    Chen, Lei
    Yang, Jiang
    Zhao, Shan-Shan
    Jin, Shi
    Ao, Na
    Yang, Jing
    Liu, Hui-Xin
    Du, Jian
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [2] Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
    Wang, Songsong
    Sheng, Feiya
    Zou, Liang
    Xiao, Jianbo
    Li, Peng
    JOURNAL OF ADVANCED RESEARCH, 2021, 34 : 109 - 122
  • [3] Gut microbiota and non-alcoholic fatty liver disease
    Gkolfakis, Paraskevas
    Dimitriadis, George
    Triantafyllou, Konstantinos
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (06) : 572 - 581
  • [4] Gut microbiota and non-alcoholic fatty liver disease
    Paraskevas Gkolfakis
    George Dimitriadis
    Konstantinos Triantafyllou
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (06) : 572 - 581
  • [5] Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
    Shen, Feng
    Zheng, Rui-Dan
    Sun, Xing-Qiang
    Ding, Wen-Jin
    Wang, Xiao-Ying
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (04) : 375 - 381
  • [6] A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease
    Dianov Petrov, Petar
    Victoria Garcia-Mediavilla, Maria
    Guzman, Carla
    Porras, David
    Nistal, Esther
    Martinez-Florez, Susana
    Vicente Castell, Jose
    Gonzalez-Gallego, Javier
    Sanchez-Campos, Sonia
    Jover, Ramiro
    MOLECULAR NUTRITION & FOOD RESEARCH, 2019, 63 (20)
  • [7] Dysbiosis of gut microbiota after cholecystectomy is associated with non-alcoholic fatty liver disease in mice
    Wang, Qihan
    Lu, Qifan
    Shao, Wentao
    Jiang, Zhaoyan
    Hu, Hai
    FEBS OPEN BIO, 2021, 11 (08): : 2329 - 2339
  • [8] The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
    Li, Zhonglin
    Yuan, Hang
    Chu, Huikuan
    Yang, Ling
    MICROORGANISMS, 2023, 11 (08)
  • [9] Non-alcoholic fatty liver and the gut microbiota
    Bashiardes, Stavros
    Shapiro, Hagit
    Rozin, Shachar
    Shibolet, Oren
    Elinav, Eran
    MOLECULAR METABOLISM, 2016, 5 (09): : 782 - 794
  • [10] Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism
    Cheng, Wei-ting
    Pei, Si-ya
    Wu, Jie
    Wang, Yan-jie
    Yang, Yong-wen
    Xiao, Mei-fang
    Chen, Jun
    Wang, Yuan-yuan
    Wu, Li
    Huang, Ze-bing
    ACTA PHARMACOLOGICA SINICA, 2025,